Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury
NCT02922894Phase 4Recruiting
- Sponsor
- John D. Dingell VA Medical Center
- Start
- Jun 2017
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of trazodone hydrochloride prolonged-release tablets in sleep apnea (3 arms), sponsored by John D. Dingell VA Medical Center. Primary endpoints: Change in Tidal Volume at 1 week, Change in CO2 reserve (Delta-PETCO2-AT) at 1 week and 2 more. Started Jun 2017; status: recruiting.
02
Drugs
trazodone hydrochloride prolonged-release tablets
03
Conditions
sleep apnea
Beyond the preview
Go deeper on NCT02922894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922894.